Ad
related to: merck pharmaceuticals
Search results
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 10 hours agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
Are Investors Undervaluing Merck KGaA (ETR:MRK) By 29%?
Simply Wall St. via Yahoo Finance· 2 days agoSWOT Analysis for Merck KGaA Strength Debt is not viewed as a risk. Dividends are covered by...
Hedge Funds Are Loading Up On This Dividend Stock
Benzinga via Yahoo Finance· 4 hours agoThe markets are adjusting to the high interest rates environment, with all the major US stock indices reporting strong gains in May 2024. However, even...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 2 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe re-agents are pivotal in manufacturing viral vectors, a key component in the development of cell...
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive via Yahoo Finance· 4 days agoMirus furthers Merck KGaA’s “ambition to provide a fully integrated and comprehensive solution for viral vector manufacturing,” the company said...
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 5 days agoKeytruda has played an instrumental role in driving Merck’s steady revenue growth in the past few...
Ken Griffin Is Snapping Up These Dividend Stocks: Hess And 2 More
Benzinga via Yahoo Finance· 3 hours agoKen Griffin, founder of Citadel in 1990, is widely regarded as a leading figure among contemporary...
Tom Still: Founders can follow different strategies to entrepreneurial success
Wisconsin State Journal· 5 hours agoOne Wisconsin example made news this week when Mirus Bio, one of the first biotechnology companies...
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 4 days agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
